Literature DB >> 19832842

Influence of hepatic artery occlusion on tumor growth and metastatic potential in a human orthotopic hepatoma nude mouse model: relevance of epithelial-mesenchymal transition.

Liang Liu1, Zheng-Gang Ren, Yuan Shen, Xiao-Dong Zhu, Wei Zhang, Wei Xiong, Yi Qin, Zhao-You Tang.   

Abstract

Hepatic artery ligation (HAL), transarterial embolization (TAE), and transarterial chemoembolization (TACE) have been treatment choices for unresectable hepatocellular carcinoma (HCC). Obstruction of tumor blood supply is one of the most important mechanisms of these therapeutics measures. Here we introduced HAL into a metastatic human HCC orthotopic nude mouse model (using MHCC97L and HepG2 cell lines) to examine the effects of hepatic blood flow obstruction on the metastatic potential of hepatic tumor cells, and to investigate the mechanisms underlying these effects. Our results indicated that HAL inhibited tumor growth but concomitantly elicited tumor adaptation and progression, with increased potential for invasion and distant metastases. The underlying proinvasive mechanism of HAL appeared to be associated with enhanced intratumoral hypoxia and epithelial-mesenchymal transition (EMT) due to hypoxia. This was in accord with the in vitro response of MHCC97L and HepG2 cells to hypoxia. The therapeutic effects of HAL could be enhanced by the phosphatidyl inositol 3-kinase (PI3K) inhibitor LY294002, through arrest of EMT in hepatic tumor cells. It could be useful in the development of mechanism-based combination therapies to enhance the initial antitumor response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19832842     DOI: 10.1111/j.1349-7006.2009.01363.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  24 in total

1.  A preclinical study on the combination therapy of everolimus and transarterial chemoembolization in hepatocellular carcinoma.

Authors:  Ariel Km Chow; Thomas Cc Yau; Lui Ng; Andrew Cy Chu; Wai-Lun Law; Ronnie Tp Poon; Roberta Wc Pang
Journal:  Am J Cancer Res       Date:  2015-07-15       Impact factor: 6.166

2.  Influence of preoperative transcatheter arterial chemoembolization on gene expression in the HIF-1α pathway in patients with hepatocellular carcinoma.

Authors:  Weiguang Xu; Jung-Hee Kwon; Young Ho Moon; Young Bae Kim; Yun Suk Yu; Namgyu Lee; Kwan Yong Choi; Yun Soo Kim; Yong Keun Park; Bong Wan Kim; Hee Jung Wang
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-23       Impact factor: 4.553

3.  Hyperpolarized Metabolic Imaging Detects Latent Hepatocellular Carcinoma Domains Surviving Locoregional Therapy.

Authors:  Nicholas R Perkons; Ryan M Kiefer; Michael C Noji; Mehrdad Pourfathi; Daniel Ackerman; Sarmad Siddiqui; David Tischfield; Enri Profka; Omar Johnson; Stephen Pickup; Anthony Mancuso; Austin Pantel; Michelle R Denburg; Gregory J Nadolski; Stephen J Hunt; Emma E Furth; Stephen Kadlecek; Terence P F Gade
Journal:  Hepatology       Date:  2020-05-16       Impact factor: 17.425

4.  Elimination plus Transformation-Chinese and Western Medicine Integration Brings Hope to Protracted War on Cancer.

Authors:  Zhao-You Tang
Journal:  Chin J Integr Med       Date:  2018-06-18       Impact factor: 1.978

5.  Phase I clinical trial of continuous infusion of tyroserleutide in patients with advanced hepatocellular carcinoma.

Authors:  Zhen-Yu Xiao; Jin-Bin Jia; Lin Chen; Wei Zou; Xiao-Ping Chen
Journal:  Med Oncol       Date:  2011-10-11       Impact factor: 3.064

6.  Pharmacologic Inhibition of the Menin-MLL Interaction Leads to Transcriptional Repression of PEG10 and Blocks Hepatocellular Carcinoma.

Authors:  Katarzyna Kempinska; Bhavna Malik; Dmitry Borkin; Szymon Klossowski; Shirish Shukla; Hongzhi Miao; Jingya Wang; Tomasz Cierpicki; Jolanta Grembecka
Journal:  Mol Cancer Ther       Date:  2017-11-15       Impact factor: 6.261

7.  Exosomal miR-155 Derived from Hepatocellular Carcinoma Cells Under Hypoxia Promotes Angiogenesis in Endothelial Cells.

Authors:  Yusuke Matsuura; Hiroshi Wada; Hidetoshi Eguchi; Kunihito Gotoh; Shogo Kobayashi; Mitsuru Kinoshita; Masahiko Kubo; Koji Hayashi; Yoshifumi Iwagami; Daisaku Yamada; Tadafumi Asaoka; Takehiro Noda; Koichi Kawamoto; Yutaka Takeda; Masahiro Tanemura; Koji Umeshita; Yuichiro Doki; Masaki Mori
Journal:  Dig Dis Sci       Date:  2018-11-22       Impact factor: 3.199

8.  Cytotoxic activity of anticancer drugs on hepatocellular carcinoma cells in hypoxic-hyponutritional culture.

Authors:  Qiang Li; Lin-Zhong Zhu; Ren-Jie Yang; Xu Zhu
Journal:  Int Surg       Date:  2014 Nov-Dec

9.  Ischemia Induces Quiescence and Autophagy Dependence in Hepatocellular Carcinoma.

Authors:  Terence P F Gade; Elizabeth Tucker; Michael S Nakazawa; Stephen J Hunt; Waihay Wong; Bryan Krock; Charles N Weber; Gregory J Nadolski; Timothy W I Clark; Michael C Soulen; Emma E Furth; Jeffrey D Winkler; Ravi K Amaravadi; M Celeste Simon
Journal:  Radiology       Date:  2017-03-02       Impact factor: 11.105

10.  A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma in nude mice.

Authors:  Jin-Bin Jia; Wen-Quan Wang; Hui-Chuan Sun; Liang Liu; Xiao-Dong Zhu; Ling-Qun Kong; Zong-Tao Chai; Wei Zhang; Ju-Bo Zhang; Hua-Xiang Xu; Zhao-Chong Zeng; Wei-Zhong Wu; Lu Wang; Zhao-You Tang
Journal:  Invest New Drugs       Date:  2010-04-23       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.